Haldol deposito 50 mg

EPS during the administration of HALDOL (haloperidol) have been reported frequently, often during the first few days of treatment. EPS can be categorized generally as Parkinson-like symptoms, akathisia, or dystonia (including opisthotonos and oculogyric crisis). While all can occur at relatively low doses, they occur more frequently and with greater severity at higher doses. The symptoms may be controlled with dose reductions or administration of antiparkinson drugs such as benztropine mesylate USP or trihexyphenidyl hydrochloride USP. It should be noted that persistent EPS have been reported; the drug may have to be discontinued in such cases.

Haldol deposito 50 mg

haldol deposito 50 mg

Media:

haldol deposito 50 mghaldol deposito 50 mghaldol deposito 50 mghaldol deposito 50 mghaldol deposito 50 mg